Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma

Pathology Research and Practice

Volumn 204, Issue 6, 2008, Pages 379-387

  Bolat, Filiz ^a   Gumurdulu, Derya ^b   Erkanli, Serkan ^a   Kayaselcuk, Fazilet ^a   Zeren, Handan ^b   Ali Vardar, M ^b   Kuscu, Esra ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Maspin; Ovarian carcinoma; Vascular endothelial growth factor A (VEGFA); VEGFC; VEGFD

Indexed keywords

MASPIN; SERINE PROTEINASE INHIBITOR; VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN D;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS; ARTICLE; ASCITES; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER STAGING; CANCER THERAPY; CANCER TISSUE; CARCINOGENESIS; CELL INVASION; CELL MOTILITY; CORRELATION ANALYSIS; ENDOMETRIOID CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; OVARY CARCINOMA; OVARY TUMOR; PAPILLARY CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; STAINING; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARY; PROGNOSIS; SERPINS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 42749090971     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.01.011     Document Type: Article

References (49)

1. Abd EL-Wahed M.M. Expression and subcellular localization of maspin in human ovarian epithelial neoplasms: correlation with clinicopathologic features. J. Egypt. Natl. Cancer Inst. 17 (2005) 173-183
2. Abulafia O., Triest W.E., and Sherer D.M. Angiogenesis in malignancies of the female genital tract. Gynecol. Oncol. 72 (1999) 220-231
3. Brown M.R., Blanchette J.O., and Kohn E.C. Angiogenesis in ovarian cancer,. Baillieres Best Pract. Res. Clin. Obstet. Gynaecol. 14 (2000) 901-918
4. Brustmann H., and Naude S. Vascular endothelial growth factor expression in serous ovarian carcinoma: relationship with high mitotic activity and high FIGO stage. Gynecol. Oncol. 84 (2002) 47-52
5. Chen C.A., Cheng W.F., Lee C.N., et al. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Gynecol. Oncol. 74 (1999) 235-240
6. Fellmer P.T., Sato K., Tanaka R R., et al. Vascular endothelial growth factor-C gene expression in papillary and follicular thyroid carcinomas. Surgery 126 (1999) 1056-1062
7. Fujimoto J., Sakaguchi H., Hirose R., Ichigo S., and Tamaya T. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer 83 (1998) 2528-2533
8. Gasparini G., Bonoldi E., Viale G., et al. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int. J. Cancer 69 (1996) 205-211
9. Hung C.J., Ginzinger D.G., Zarnegar R., et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J. Clin. Endocrinol. Metab. 88 (2003) 3694-3699
10. International Federation of Gynecology and Obstetrics. Classification and staging malignant tumors in the female pelvis. Acta Obstet. Gynecol. Scand. 50 (1971) 1-7
11. Ito Y., Yoshida H., Tomoda C., et al. Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma. Thyroid 14 (2004) 13-18
12. Jiang H.G., Gao M., Tang W.P., Li F.H., and Cai Q.Z. Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma. Ai. Zheng 24 (2005) 1136-1139
13. Karpanen T., Egeblad M., Karkkainen M.J., et al. Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth. Cancer Res. 61 (2001) 1786-1790
14. Khalkhali-Ellis Z., Christian A.L., Kirschmann D.A., et al. Regulating the tumor suppressor gene maspin in breast cancer cells: a potential mechanism for the anticancer properties of tamoxifen. Clin. Cancer Res. 10 (2004) 449-454
15. Li H.W., Leung S.W., Chan C.S., Yu M.M., and Wong Y.F. Expression of maspin in endometrioid adenocarcinoma of endometrium. Oncol. Rep. 17 (2007) 393-398
16. Li J.J., Chen Y., Zhang S.M., et al. Pathobiological significance of vascular endothelial growth factor and maspin expressions in human gastric carcinoma. World J. Gastroenterol. 10 (2004) 2624-2627
17. Maass N., Hojo T., Rosel F., Ikeda T., Jonat W., and Nagasaki K. Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin. Biochem. 34 (2001) 303-307
18. Maass N., Hojo T., Ueding M., et al. Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin. Cancer Res. 7 (2001) 812-817
19. Mohsin S.K., Zhang M., Clark G.M., and Craig Allred D. Maspin expression in invasive breast cancer: association with other prognostic factors. J. Pathol. 199 (2003) 432-435
20. Nicosia R.F. What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?. Am. J. Pathol. 153 (1998) 11-16
21. Niki T., Iba S., Tokunou M., Yamada T., Matsun Y., and Hirohashi S. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma. Clin. Cancer Res. 6 (2000) 2431-2439
22. Nishida N., Yano H., Komai K., Nishida T., Kamura T., and Kojiro M. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma. Cancer 101 (2004) 1364-1374
23. Oehler M.K., and Caffier H. Diagnostic value of serum VEGF in women with ovarian tumors. Anticancer Res. 19 (1999) 2519-2522
24. Ogawa S., Kaku T., Kobayashi H., et al. Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma. Cancer Lett. 176 (2002) 111-118
25. Pemberton P.A., Tipton A.R., Pavloff N., et al. Maspin is an intracellular serpin that partitions into secretory vesicles and is present at the cell surface. J. Histochem. Cytochem. 45 (1997) 1697-1706
26. Pierson C.R., McGowen R., Grignon D., Sak W., Dey J., and Sheng S. Maspin is up-regulated in premalignant prostate epithelia. Prostate 53 (2002) 255-262
27. Rose S.L., Fitzgerald M.P., White N.O., et al. Epigenetic regulation of maspin expression in human ovarian carcinoma cells. Gynecol. Oncol. 102 (2006) 319-324
28. Salvesen H.B., and Akslen L.A. Significance of tumour-associated macrophages, vascular endothelial growth factor and thrombospondin-1 expression for tumour angiogenesis and prognosis in endometrial carcinomas. Int. J. Cancer 84 (1999) 538-543
29. Secord A.A., Lee P.S., Darcy K.M., et al. Gynecologic Oncology Group. Maspin expression in epithelial ovarian cancer and associations with poor prognosis. A Gynecologic Oncology Group study. Gynecol. Oncol. 101 (2006) 390-397
30. Shushanov S., Bronstein M., Adelaide J., et al. VEGFc and VEGFR3 expression in human thyroid pathologies. Int. J. Cancer 86 (2000) 47-52
31. Solomon L.A., Munkarah A.R., Schimp V.L., et al. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer. Gynecol. Oncol. 101 (2006) 385-389
32. Song S.Y., Lee S.K., Kim D.H., et al. Expression of maspin in colon cancers: its relationship with p53 expression and microvessel density. Dig. Dis. Sci. 47 (2002) 1831-1835
33. Sood A.K., Fletcher M.S., Gruman M.L., et al. The paradoxical expression of maspin in ovarian carcinoma. Clin. Cancer Res. 8 (2002) 2924-2932
34. Sowter H.M., Corps A.N., Evans A.L., et al. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab. Invest. 77 (1997) 607-614
35. Surowiak P., Materna V., Drag-Zalesinska M., et al. Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates. Int. J. Gynecol. Pathol. 25 (2006) 131-139
36. Terashima M., Maesawa C., Oyama K., et al. Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br. J. Cancer 92 (2005) 1130-1136
37. Ueda M., Hung Y.C., Terai Y., et al. Vascular endothelial growth factor-C expression and invasive phenotype in ovarian carcinomas. Clin. Cancer Res. 11 (2005) 3225-3232
38. Ueda M., Terai Y., Kumagai K., et al. Vascular endothelial growth factor C gene expression is closely related to invasion phenotype in gynecological tumor cells. Gynecol. Oncol 82 (2001) 162-166
39. Wang M.C., Yang Y.M., Li X.H., Dong F., and Li Y. Maspin expression and its clinicopathological significance in tumorigenesis and progression of gastric cancer. World J. Gastroenterol. 10 (2004) 634-637
40. Yamamoto S., Konishi I., Mandai M., et al. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br. J. Cancer 76 (1997) 1221-1227
41. 2 overexpression correlates with increased expression of vascular endothelial growth factors A, C and D in human breast carcinoma. Cancer 94 (2002) 2855-2861
42. Yasuoka H., Nakamura Y., Zuo H., et al. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod. Pathol. 18 (2005) 1127-1133
43. Yatabe Y., Mitsudomi T., and Takahashi T. Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylation. Oncogene 23 (2004) 4041-4049
44. Yokoyama Y., Charnock-Jones D.S., Licence D., et al. Vascular endothelial growth factor-D is an independent prognostic factor in epithelial ovarian carcinoma. Br. J. Cancer 88 (2003) 237-244
45. Yu X.M., Lo C.Y., Chan W.F., et al. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases. Clin. Cancer Res. 11 (2005) 8063-8069
46. Zhang G.H., Zeng Y., Yang W.T., and Shi D.R. Study of mRNA expression of vascular endothelial growth factor-(A, C, D) genes and its effect on prognosis of breast cancer. Zhonghua Bing Li Xue Za Zhi 35 (2006) 473-477
47. Zhang M., Volpert O., Shi Y.H., and Bouck N. Maspin is an angiogenesis inhibitor. Nat. Med. 6 (2000) 196-199
48. Zou Z., Anisowicz A., Hendrix M.J., et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cell. Science 263 (1994) 526-529
49. Zou Z., Gao C., Nagaich A.K., et al. P53 Regulates the expression of the tumor suppressor gene maspin. J. Biol. Chem. 275 (2000) 6051-6054